Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients

Simona Arientová, Kateřina Matúšková, Oldřich Bartoš, Ondřej Beran, Michal Holub

Open source

DOI
10.3390/jcm13216340
Published
2024-10-23
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm13216340,
  title = {Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients},
  author = {Simona Arientová and Kateřina Matúšková and Oldřich Bartoš and Ondřej Beran and Michal Holub},
  year = {2024},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm13216340},
  url = {https://doi.org/10.3390/jcm13216340}
}

RIS

TY  - JOUR
TI  - Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients
AU  - Simona Arientová
AU  - Kateřina Matúšková
AU  - Oldřich Bartoš
AU  - Ondřej Beran
AU  - Michal Holub
PY  - 2024
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm13216340
UR  - https://doi.org/10.3390/jcm13216340
ER  - 

APA

Arientová, S., Matúšková, K., Bartoš, O., Beran, O., & Holub, M. (2024). Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13216340

Source records